V. Sibaud

6.3k total citations · 1 hit paper
158 papers, 3.5k citations indexed

About

V. Sibaud is a scholar working on Oncology, Dermatology and Epidemiology. According to data from OpenAlex, V. Sibaud has authored 158 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Oncology, 60 papers in Dermatology and 30 papers in Epidemiology. Recurrent topics in V. Sibaud's work include Cancer Immunotherapy and Biomarkers (33 papers), Chemotherapy-related skin toxicity (29 papers) and Colorectal Cancer Treatments and Studies (24 papers). V. Sibaud is often cited by papers focused on Cancer Immunotherapy and Biomarkers (33 papers), Chemotherapy-related skin toxicity (29 papers) and Colorectal Cancer Treatments and Studies (24 papers). V. Sibaud collaborates with scholars based in France, United States and Italy. V. Sibaud's co-authors include Mario E. Lacouture, Émmanuelle Vigarios, C. Taïeb, L. Misery, Nicolás Meyer, Laurence Lamant, Joel B. Epstein, Caroline Robert, C Merial‐Kieny and Jean Pierre Delord and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and The Lancet Oncology.

In The Last Decade

V. Sibaud

138 papers receiving 3.4k citations

Hit Papers

Dermatologic Reactions to Immune Checkpoint Inhibitors 2017 2026 2020 2023 2017 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
V. Sibaud France 30 1.7k 1.4k 542 492 439 158 3.5k
Motonobu Nakamura Japan 29 871 0.5× 872 0.6× 748 1.4× 249 0.5× 1.0k 2.3× 184 3.4k
Joseph G. Morelli United States 31 465 0.3× 1.4k 1.0× 492 0.9× 591 1.2× 411 0.9× 122 3.7k
Shawn G. Kwatra United States 35 517 0.3× 2.5k 1.8× 248 0.5× 545 1.1× 587 1.3× 254 3.7k
Ted Hamilton United States 35 580 0.3× 2.5k 1.8× 648 1.2× 451 0.9× 585 1.3× 55 3.9k
Michele Davide Mignogna Italy 36 523 0.3× 404 0.3× 673 1.2× 458 0.9× 158 0.4× 177 4.3k
P.E. Hutchinson United Kingdom 31 489 0.3× 1.3k 1.0× 502 0.9× 587 1.2× 919 2.1× 83 3.0k
Deborah Phippard United States 26 410 0.2× 428 0.3× 773 1.4× 250 0.5× 764 1.7× 42 4.1k
Alfredo Rossi Italy 31 205 0.1× 1.0k 0.7× 402 0.7× 406 0.8× 246 0.6× 151 3.1k
Min Zheng China 30 400 0.2× 853 0.6× 1.0k 1.9× 301 0.6× 1.1k 2.5× 158 3.0k
S Gandolfo Italy 38 521 0.3× 657 0.5× 316 0.6× 424 0.9× 107 0.2× 127 4.5k

Countries citing papers authored by V. Sibaud

Since Specialization
Citations

This map shows the geographic impact of V. Sibaud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Sibaud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Sibaud more than expected).

Fields of papers citing papers by V. Sibaud

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. Sibaud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Sibaud. The network helps show where V. Sibaud may publish in the future.

Co-authorship network of co-authors of V. Sibaud

This figure shows the co-authorship network connecting the top 25 collaborators of V. Sibaud. A scholar is included among the top collaborators of V. Sibaud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. Sibaud. V. Sibaud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pagès, Cécile, et al.. (2025). Rare Immuno-Induced Keratoacanthomas Showed on 18F-FDG PET/CT in a Metastatic Melanoma Patient. Clinical Nuclear Medicine. 50(5). e288–e289. 1 indexed citations
2.
Ortiz‐Brugués, Ariadna & V. Sibaud. (2024). Syndrome main-pied. 4(7). 512–513.
3.
Sibaud, V., Cécile Pagès, K. Delavigne, et al.. (2024). Revue des atteintes dermatologiques atypiques et/ou systémiques en lien avec les inhibiteurs de checkpoints immunologiques. La Revue de Médecine Interne. 46(7). 369–376. 1 indexed citations
4.
Sibaud, V. & Pietro Sollena. (2023). Dermatologic toxicities to inhibitors of cyclin-dependent kinases CDK 4 and 6: An updated review for clinical practice. Annales de Dermatologie et de Vénéréologie. 150(3). 208–212. 14 indexed citations
5.
Vigarios, Émmanuelle & V. Sibaud. (2023). Oral mucosal toxicities induced by immune checkpoint inhibitors: Clinical features and algorithm management. Annales de Dermatologie et de Vénéréologie. 150(2). 83–88. 5 indexed citations
6.
Girard, C., Juliette Rochefort, C. Roux, et al.. (2021). Recommandations pour la prise en charge du lichen oral du groupe d’étude de la muqueuse buccale. 1(8). A67–A67.
7.
Apalla, Zoé, Bernardo L. Rapoport, & V. Sibaud. (2021). Dermatologic immune-related adverse events: The toxicity spectrum and recommendations for management. International Journal of Women’s Dermatology. 7(5). 625–635. 31 indexed citations
8.
Sibaud, V., Alain Cantagrel, Mario Di Palma, et al.. (2021). Gestion des toxicités des inhibiteurs BRAF et MEK dans le mélanome métastatique. Bulletin du Cancer. 108(5). 528–543. 3 indexed citations
9.
Massabeau, Carole, et al.. (2020). Oral mucosal changes induced by adjuvant endocrine therapies in breast cancer patients: clinical aspects and proposal for management. Supportive Care in Cancer. 29(4). 1719–1722. 6 indexed citations
10.
Vigarios, Émmanuelle, et al.. (2019). Geographic stomatitis with palate involvement. Anais Brasileiros de Dermatologia. 94(4). 449–451. 11 indexed citations
11.
Sibaud, V., É. Tournier, Laurence Lamant, et al.. (2019). Multiple Keratoacanthoma-like Lesions in a Patient Treated with Pembrolizumab. Acta Dermato Venereologica. 99(13). 1201–1302. 8 indexed citations
12.
Vigarios, Émmanuelle, Joel B. Epstein, & V. Sibaud. (2017). Oral mucosal changes induced by anticancer targeted therapies and immune checkpoint inhibitors. Supportive Care in Cancer. 25(5). 1713–1739. 107 indexed citations
13.
Sibaud, V., et al.. (2017). Panniculitis Associated with MEK Inhibitor Therapy: An Uncommon Adverse Effect. Case Reports in Dermatology. 9(1). 80–85. 6 indexed citations
14.
Dai, Julia, Viswanath Reddy Belum, Shenhong Wu, V. Sibaud, & Mario E. Lacouture. (2017). Pigmentary changes in patients treated with targeted anticancer agents: A systematic review and meta-analysis. Journal of the American Academy of Dermatology. 77(5). 902–910.e2. 49 indexed citations
15.
Konstantinou, Maria Polina, É. Tournier, Haleh Bagheri, et al.. (2016). Enzalutamide induced acute generalized exanthematous pustulosis. Journal of Dermatological Case Reports. 10(2). 35–38. 10 indexed citations
16.
Regnault, M. Masson, S. Boulinguez, É. Tournier, et al.. (2015). Chemotherapy-Related Reticulate Hyperpigmentation: A Case Series and Review of the Literature. Dermatology. 231(4). 312–318. 13 indexed citations
17.
Hubiche, Thomas & V. Sibaud. (2014). Localized acne induced by radiation therapy. Dermatology Online Journal. 20(2). 8 indexed citations
18.
Barbarot, S., et al.. (2009). Patient-Oriented SCORAD: A Self-Assessment Score in Atopic Dermatitis. Dermatology. 218(3). 246–251. 50 indexed citations
19.
Fricain, Jean‐Christophe, et al.. (2008). Ulcérations buccales chez les patients transplantés rénaux traités par sirolimus. Annales de Dermatologie et de Vénéréologie. 135(11). 737–741. 14 indexed citations
20.
Delbrel, X., V. Sibaud, O. Cogrel, et al.. (2003). Placards pseudocellulitiques multiples et signe de Koplick : une forme originale de primo-infection à parvovirus B19 de l'adulte. La Revue de Médecine Interne. 24(5). 317–319. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026